How a cannabis-derived therapy may help COVID patients

1 min read

Since 2018, Business of Cannabis has produced Medical Cannabis Week to surface and celebrate insights and innovations from patients, practitioners and the industry. While a full week, in-person Medical Cannabis Week event was not possible in May 2020, we moved ahead with a weeklong, virtual Medical Cannabis Week in November 2020.

Jay Rosenthal of Business of Cannabis joins Dr. Guy Chamberland, PhD, CEO and Chief Regulatory Officer of Tetra Bio-Pharma to understand the research Tetra Bio-Pharma is currently engaged related to a drug that has therapeutic promise for treating COVID-19 patients.

Learn more about Tetra Bio-Pharma.

Previous Story

How to use data to create better cannabis products for patients

Next Story

How New Brunswick is creating an innovation and research advantage

0 $0.00